Inventor · disambiguated record
Christopher M. Clemens
Also filed as: CLEMENS CHRISTOPHER · CLEMENS CHRISTOPHER M
8 granted patents·3 pending applications·334 citations·filing 1993–2016
91Inventor score
Files withOPHIDIAN PHARM INC5IVDIAGNOSTICS INC2PROMEGA CORP2WATSON LAB INC1WATSON PHARMACEUTICALS INC1
Top patents by PatentIndex Score
11 records- 0189US5601823AAvian antitoxins to clostridium difficle toxin AOPHIDIAN PHARM INC·Filed 1993·Granted Feb 11, 1997·81 cites·15 claims
- 0280US5762934AClostridium difficile toxin disease therapyOPHIDIAN PHARM INC·Filed 1995·Granted Jun 9, 1998·45 cites·16 claims
- 0379US5719267AClostridial toxin disease therapyOPHIDIAN PHARM INC·Filed 1995·Granted Feb 17, 1998·44 cites·10 claims
- 0478US6251866B1Conjugates targeted to the interleukin-2 receptorWATSON LAB INC·Filed 1998·Granted Jun 26, 2001·44 cites·27 claims
- 0575US5599539ATherapy for clostridial botulinum toxinOPHIDIAN PHARM INC·Filed 1994·Granted Feb 4, 1997·50 cites·10 claims
- 0674US5814477ARecombinant clostridial toxin proteinOPHIDIAN PHARM INC·Filed 1995·Granted Sep 29, 1998·33 cites·5 claims
- 0769US6656468B1Clostridial toxin disease therapyPROMEGA CORP·Filed 1997·Granted Dec 2, 2003·26 cites·15 claims
- 0861US2004062771A1Clostridial toxin disease therapyPROMEGA CORP·Filed 2003·Application pending·0 cites
- 0955US6693083B2Conjugates targeted to the interleukin-2 receptorWATSON PHARMACEUTICALS INC·Filed 2001·Granted Feb 17, 2004·11 cites·20 claims
- 1037US2016282353A1Systems and methods of detecting malignant cellsIVDIAGNOSTICS INC·Filed 2016·Application pending·0 cites
- 1137US2019380626A1Multimodal systems and methods for detecting and quantitating cell or other particle targets in a bloodstream of a living beingIVDIAGNOSTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher M. Clemens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →